News & Updates

New drug applications approved by US FDA as of 01-15 May 2023 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Married women cite having enough children and the lack of financial capability to afford another child as the main reasons for having an abortion, according to a Singapore study, noting the need for better family planning and contraceptive counselling to prevent unwanted pregnancies.

A breast cancer diagnosis may just be right at our fingertips, literally.

Treatment with cabergoline appears to reduce breast engorgement and other symptoms related to lactation in women following second-trimester abortion or pregnancy loss, as shown in a study.

New drug applications approved by US FDA as of 16-30 April 2023 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

A home-use, therapeutic ultrasound device appears to be safe and perform well for treating vaginal dryness, with efficacy maintained for up to 1 year, as shown in the results of a pilot study.